Nanotechnology in Medical Applications: The Global Market

Report Code: HLC069A

Publish Date: Jan 2010

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2750

Member Price: FREE

Use code SUMMER at checkout for 50% OFF

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The global nanomedicine market was valued at $53 billion in 2009, and is forecast to increase at a compound annual growth rate (CAGR) of 13.5% to reach more than $100 billion in 2014. 
  • Nanomedical products for cancer are one of the largets market segments, worth nearly $20 billion in 2009. This sector is expected to increase at a compound annual growth rate (CAGR) of 11% to reach $33 billion in 2014.
  • Nanomedicine for CNS indications is another major market sector, valued at nearly $11 billion in 2009 and expected to reach $18 billion by 2014, an 11.1% compound annual growth rate (CAGR).

INTRODUCTION 

STUDY GOALS AND OBJECTIVES
 
The aim of this report is to provide detailed market, technology and industry analyses to help readers quantify and qualify the market for prescription drug products incorporating nanotechnology features. Important trends are identified and sales forecasts by product categories and major country markets are provided through 2014; these are based on industry sources and considered assessment of the regulatory environment, healthcare policies, demographics, and other factors that directly affect the nanomedicine-related drug market. The wider economic environment is also taken into account. 
The report examines strategies employed by companies specializing in nanomedicine to meet the challenges of this highly competitive market. 
REASONS FOR DOING THE STUDY
 
Nanomedicine is transforming itself into an established market. Unlike some of the farther shores of nanotechnology, which are still largely experimental in nature, nanomedicine has already produced a healthy crop of significant products in which the nano dimension has made a significant contribution to product effectiveness. As the market grows towards maturity, it is timely to review the technology, see its practical applications so far, evaluate the participating companies, and look to the future of this marketplace. 
INTENDED AUDIENCE
 
This report is designed to satisfy the information needs of a wide variety of individuals involved in the pharmaceutical marketplace, including company senior management executives seeking to base their strategic decisions on the best available information on market forces and trends. However, it is also aimed at managers and executives in marketing, research, planning, and sales departments who need readable, comprehensive, and up-to-date background on the marketplace in which they are operating.
SCOPE OF REPORT 
This report discusses the implications of technology and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets. The important technologies supporting nanomedicine are reviewed, and the nature and structure of the nanomedicine industry is discussed with profiles of the leading 60-plus companies, including recent M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved. 
MARKET ANALYSES AND FORECASTS
 
Market figures are based on revenues at the manufacturer level and are projected at 2009-dollar value without attempting to predict the effect of inflation or deflation. 
Therapeutic categories quantified and forecast include cancer, CNS diseases, infections, and cardiovascular.   Country markets analyzed are the U.S., Japan, Germany, France, the UK, Italy, and Spain. 
METHODOLOGY
 
Both primary and secondary research methodologies were used when examining this market. Primary research includes interviews with leading individuals in nanomedicine companies and industry associations. Primary sources of published data include company annual reports, SEC filings, and government and industry publications. Secondary sources consist of literature searches, industry journals, and other commercial publications. Data for market estimates and forecasts are pooled from a range of sources, critically assessed by BCC. 
INFORMATION SOURCES
 
Sources of information included marketing strategists, industry executives, government agencies and regulatory bodies, and surveys of physicians and pharmacists. Company annual reports and SEC filings, journal articles, and data from healthcare institutions were also mined, as well as publications of relevant trade associations.
ANALYST CREDENTIALS 
Paul Evers has been involved in analyzing pharmaceutical and medical markets for 20 years. He is the author of previous reports on the nanomedicine marketplace as well as analyses of major therapeutic categories and the pharmaceutical regulatory environment. 
BCC ONLINE SERVICES 
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers 
DISCLAIMER 

The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Nanotechnology in Medical Applications: The Global Market184Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY3Free
Chapter- 3: OVERVIEW10Free
Chapter- 4: NANOMEDICINE67Free
Chapter- 5: C. CRAMER & CO. GMBH98Free
Chapter- 6: APPENDIX: 3Free

Related Reports

Recent Reports

Microelectronic Medical Implants: Products, Technologies & Opportunities

Published - Jul 2024 | Publisher - BCC Publishing | Code - HLC016F

The global market for microelectronic medical implants is expected to grow from $49.0 billion in 2024 and is projected to reach $85.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.7% during the forecast period of 2024 to 2029. 

Wearable Medical Devices: Technologies and Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - HLC192D

The global market for wearable medical devices was valued at $35.6 billion in 2023. This market is estimated to grow from $45.0 billion in 2024 to $151.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.5% from 2024 through 2029.

Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - HLC176E

The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.

Routine Health Screening Market

Published - Jul 2024 | Publisher - BCC Publishing | Code - HLC299A

The global market for routine health screening is expected to grow from $59.7 billion in 2024 and is projected to reach $82.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.

Elder Care Services and Assistive Devices: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - HLC062E

The global market for elder care services and assistive devices is expected to grow from $868.2 billion in 2024 and is projected to reach $1.1 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.

Top Trending Reports

Sensors: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - IAS006P

The global market for sensors is estimated to increase from $179.7 billion in 2023 to reach $300.5 billion by 2029, at a compound annual growth rate (CAGR) of 8.9% from 2024 through 2029.

Solid State Batteries: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - FCB053B

The global market for solid state batteries is estimated to increase from $274.0 million in 2023 to reach $1.7 billion by 2029, at a compound annual growth rate (CAGR) of 36.7% from 2024 through 2029.

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Hydrogen Storage: Materials, Technologies and Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - EGY146C

The global market for hydrogen storage materials and technologies is expected to grow from $5.3 billion in 2023 to $7.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.

Life Science Tools and Reagents: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO083E

The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Nanotechnology in Medical Applications: The Global Market
Customize Report